Assessment of the charlson comorbidity index score, CHADS2 and CHA2DS2-VASc scores in predicting death in patients with thoracic empyema

作者：Wu Jengyuan; Liu Chienming; Lee Shangsen; Kuo Yuhung; Hsieh Tengfu^*

来源：Heart & Lung, 2018, 47(2): 157-161.

DOI：10.1016/j.hrtlng.2017.12.003

• Charlson comorbidity index score
• Death
• Predict
• Risk
• Thoracic empyema

Background: Patients with thoracic empyema have an increased risk of mortality, but their absolute rate of mortality depends on age and comorbidities.
Objective: This study seeks to assess the predictive value of the Charlson Comorbidity Index score (CCIS), CHADS2 and CHA2DS2-VASc scores for mortality risk in patients with empyema thoracis.
Methods: From Taiwan's National Health Insurance Research Database we identified a total of 484 participants diagnosed with thoracic empyema. The CCIS, CHADS2 and CHA2DS2-VASc scores were used to stratify mortality risk.
Results: The incidence rate of mortality in the present study was 20.39 per 1000 person-months. A strong correlation was found between thoracic empyema and CCIS score.
Conclusions: Our results show that patients with thoracic empyema have a significantly high incidence rate of mortality and that CCIS can be used as an indicator of risk for mortality.

• 出版日期2018-4